Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
| Status: | Completed |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/2/2019 |
| Start Date: | February 3, 2017 |
| End Date: | March 4, 2017 |
The objective of the study is to demonstrate effectiveness of the G6 sensor membrane, in
preventing acetaminophen's interference effect on glucose sensing.
preventing acetaminophen's interference effect on glucose sensing.
The interference effect of the sensor will be evaluated by comparing the bias in the glucose
values exhibited from the G6 CGM system after administration of acetaminophen. Bias will be
evaluated by comparing CGM values to a laboratory referenceusing venous sample measurements.
values exhibited from the G6 CGM system after administration of acetaminophen. Bias will be
evaluated by comparing CGM values to a laboratory referenceusing venous sample measurements.
Inclusion Criteria:
- Ages 18 or older
- Diagnosis of diabetes
Exclusion Criteria:
- Pregnancy
- Known gastroparesis
- Abnormal liver function
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials